Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers

Advances in Colloid and Interface Science

Volumn 207, Issue 1, 2014, Pages 81-92

  Relini, Annalisa ^a,b   Marano, Nadia ^a,c   Gliozzi, Alessandra ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Research Center on the Molecular Basis of Neurodegeneration   (Italy)

^c ST LAWRENCE UNIVERSITY   (United States)

Author keywords

Amyloid aggregation; Amyloid toxicity; Membrane model systems; Membrane permeabilization; Membrane assisted fibrillogenesis

Indexed keywords

GLYCOPROTEINS; LIPID BILAYERS; LIPIDS; MONOLAYERS;

AMYLOIDOGENIC PROTEINS; EXPERIMENTAL EVIDENCE; FIBRILLOGENESIS; HYDROPHOBIC ENVIRONMENT; MEMBRANE MODELING; MEMBRANE PERMEABILIZATION; PROTEIN CONCENTRATIONS; THREE DIMENSIONAL SYSTEMS;

PROTEINS;

AMYLOID PROTEIN; LIPID BILAYER; LIPOSOME; MEMBRANE PROTEIN;

ANIMAL; BIOLOGICAL MODEL; BIOPHYSICS; CHEMICAL PHENOMENA; CHEMISTRY; HUMAN; LIPID BILAYER; METABOLISM; PROTEINOSIS; SURFACE PROPERTY; UPREGULATION;

AMYLOIDOGENIC PROTEINS; ANIMALS; BIOPHYSICAL PHENOMENA; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPID BILAYERS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN AGGREGATION, PATHOLOGICAL; SURFACE PROPERTIES; UNILAMELLAR LIPOSOMES; UP-REGULATION;

EID: 84901197855     PISSN: 00018686     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cis.2013.10.015     Document Type: Review

References (132)

1. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu Rev Biochem 75 2006 333 366
2. D. Eisenberg, and M. Jucker The amyloid state of proteins in human diseases Cell 148 2012 1188 1203
3. Y. Yoshimura, Y. Lin, H. Yagi, Y.H. Lee, H. Kitayama, and K. Sakurai et al. Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation Proc Natl Acad Sci U S A 109 2012 14446 14451
4. R. Gaspari, A. Gliozzi, and R. Ferrando Aggregation phenomena in a system of molecules with two internal states Phys Rev E 76 2007 041604
5. R. Kodali, and R. Wetzel Polymorphism in the intermediates and products of amyloid assembly Curr Opin Struct Biol 17 2007 48 57
6. V.N. Uversky Mysterious oligomerization of the amyloidogenic proteins FEBS J 277 2010 2940 2953
7. A. Laganowsky, C. Liu, M.R. Sawaya, J.P. Whitelegge, J. Park, and M. Zhao et al. Atomic view of a toxic amyloid small oligomer Science 335 2012 1228 1231
8. J.C. Stroud, C. Liu, P.K. Teng, and D. Eisenberg Toxic fibrillar oligomers of amyloid-β have cross-β structure Proc Natl Acad Sci U S A 109 2012 7717 7722
9. A. Petkova, R. Leapman, Z. Guo, W. Yau, M. Mattson, and R. Tycko Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils Science 307 2005 262 265
10. J. Meinhardt, C. Sachse, P. Hortschansky, N. Grigorieff, and M. Faendrich A beta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils J Mol Biol 386 2009 869 877
11. A.R.A. Ladiwala, J. Litt, R.S. Kane, D.S. Aucoin, S.O. Smith, and S. Ranjan et al. Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity J Biol Chem 287 2012 24765 24773
12. S. Campioni, B. Mannini, M. Zampagni, A. Pensalfini, C. Parrini, and E. Evangelisti et al. A causative link between the structure of aberrant protein oligomers and their toxicity Nat Chem Biol 6 2010 140 147
13. R. Kodali, A.D. Williams, S. Chemuru, and R. Wetzel A beta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated J Mol Biol 401 2010 503 517
14. G.P. Gorbenko, and P.K. Kinnunen The role of lipid-protein interactions in amyloid-type protein fibril formation Chem Phys Lipids 141 2006 72 82
15. T. Okada, M. Wakabayashi, K. Ikeda, and K. Matsuzaki Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component J Mol Biol 371 2007 481 489
16. M. Kosicek, and S. Hecimovic Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers Int J Mol Sci 14 2013 1310 1322
17. H. Möwald Surfactant layers at water surfaces Rep Prog Phys 56 1993 653 685
18. T.L. Williams, and L.C. Serpell Membrane and surface interactions of Alzheimer's A beta peptide - insights into the mechanism of cytotoxicity FEBS J 278 2011 3905 3917
19. F.T. Arce, H. Jang, S. Ramachandran, P.B. Landon, R. Nussinov, and R. Lal Polymorphism of amyloid beta peptide in different environments: implications for membrane insertion and pore formation Soft Matter 7 2011 5267 5273
20. G. Di Natale, G. Pappalardo, D. Milardi, M.F.M. Sciacca, F. Attanasio, and D. La Mendola et al. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments J Phys Chem B 114 2010 13830 13838
21. I. Mikhalyov, A. Olofsson, G. Grobner, and L.B. Johansson Designed fluorescent probes reveal interactions between amyloid-beta(1-40) peptides and G(M1) gangliosides in micelles and lipid vesicles Biophys J 99 2010 1510 1519
22. J. Fantini, and N. Yahi Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases Expert Rev Mol Med 12 2010 e27
23. Y. Sun, C. Lee, T. Chen, and H.W. Huang Kinetic process of beta-amyloid formation via membrane binding Biophys J 99 2010 544 552
24. Y. Mao, Z. Shang, Y. Imai, T. Hoshino, R. Tero, and M. Tanaka et al. Surface-induced phase separation of a sphingomyelin/cholesterol/ganglioside GM1-planar bilayer on mica surfaces and microdomain molecular conformation that accelerates A beta oligomerization Biochim Biophys Acta-Biomembr 1798 2010 1090 1099
25. M. Sani, J.D. Gehman, and F. Separovic Lipid matrix plays a role in Abeta fibril kinetics and morphology FEBS Lett 585 2011 749 754
26. M. Stefani Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits Prog Neurobiol 99 2012 226 245
27. K.A. Burke, E.A. Yates, and J. Legleiter Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration Front Neurol 4 2013 17
28. S. Rocha, J.A. Loureiro, G. Brezesinski, and MdC Pereira Peptide-surfactant interactions: consequences for the amyloid-beta structure Biochem Biophys Res Commun 420 2012 136 140
29. C. Cecchi, D. Nichino, M. Zampagni, C. Bernacchioni, E. Evangelisti, and A. Pensalfini et al. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells Biochim Biophys Acta-Biomembr 1788 2009 2204 2216
30. K. Matsuzaki, K. Kato, and K. Yanagisawa Abeta polymerization through interaction with membrane gangliosides BBA-Mol Cell Biol 2010 1801 868 877
31. G. Gorbenko, and V. Trusova Protein aggregation in a membrane environment Adv Protein Chem Struct Biol 84 2011 113 142
32. Y.A. Domanov, and P.K.J. Kinnunen Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers J Mol Biol 376 2008 42 54
33. N.P. Reynolds, A. Soragni, M. Rabe, D. Verdes, E. Liverani, and S. Handschin et al. Mechanism of membrane interaction and disruption by alpha-synuclein J Am Chem Soc 133 2011 19366 19375
34. M.F. Engel, C.C. vandenAkker, M. Schleeger, K.P. Velikov, G.H. Koenderink, and M. Bonn The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution J Am Chem Soc 134 2012 14781 14788
35. M. Zhu, P. Souillac, C. Ionescu-Zanetti, S. Carter, and A. Fink Surface-catalyzed amyloid fibril formation J Biol Chem 277 2002 50914 50922
36. A. Relini, C. Canale, S. De Stefano, R. Rolandi, S. Giorgetti, and M. Stoppini et al. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis J Biol Chem 281 2006 16521 16529 10.1074/jbc.M513827200
37. E.Y. Chi, C. Ege, A. Winans, J. Majewski, G. Wu, and K. Kjaer et al. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide Proteins 72 2008 1 24
38. J. Dorosz, R. Volinsky, E. Bazar, S. Kolusheva, and R. Jelinek Phospholipid-induced fibrillation of a prion amyloidogenic determinant at the air/water interface Langmuir 25 2009 12501 12506
39. H.P. Ta, K. Berthelot, B. Coulary-Salin, B. Desbat, J. Géan, and L. Servant et al. Comparative studies of nontoxic and toxic amyloids interacting with membrane models at the air-water interface Langmuir 27 2011 4797 4807
40. E. Maltseva, and G. Brezesinski Adsorption of amyloid beta (1-40) peptide to phosphatidylethanolamine monolayers Chemphyschem 5 2004 1185 1190
41. D. Xiao, L. Fu, J. Liu, V.S. Batista, and E.C.Y. Yan Amphiphilic adsorption of human islet amyloid polypeptide aggregates to lipid/aqueous interfaces J Mol Biol 421 2012 537 547
42. F. Evers, C. Jeworrek, S. Tiemeyer, K. Weise, D. Sellin, and M. Paulus et al. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study J Am Chem Soc 131 2009 9516 9521
43. M. McMasters, R. Hammer, and R. McCarley Surface-induced aggregation of beta amyloid peptide by omega-substituted alkanethiol monolayers supported on gold Langmuir 21 2005 4464 4470
44. L. Nault, P. Guo, B. Jain, Y. Brechet, F. Bruckert, and M. Weidenhaupt Human insulin adsorption kinetics, conformational changes and amyloidal aggregate formation on hydrophobic surfaces Acta Biomater 9 2013 5070 5079
45. J. Zhai, T. Lee, D.H. Small, and M. Aguilar Characterization of early stage intermediates in the nucleation phase of a beta aggregation Biochemistry 51 2012 1070 1078
46. Q. Wang, N. Shah, J. Zhao, C. Wang, C. Zhao, and L. Liu et al. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers Phys Chem Chem Phys 13 2011 15200 15210
47. S. Rocha, R. Krastev, A.F. Thünemann, M.C. Pereira, H. Möhwald, and G. Brezesinski Adsorption of amyloid β-peptide at polymer surfaces: a neutron reflectivity study Chemphyschem 6 2005 2527 2534
48. A.M. Saraiva, M.C. Pereira, and G. Brezesinski Is the viscoelasticity of Alzheimer's Abeta 42 peptide oligomers a general property of protein oligomers related to their toxicity? Langmuir 26 2010 12060 12067
49. L. Shen, T. Adachi, D. Vanden Bout, and X. Zhu A mobile precursor determines amyloid-beta peptide fibril formation at interfaces J Am Chem Soc 134 2012 14172 14178
50. A. Relini, O. Cavalleri, R. Rolandi, and A. Gliozzi The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes Chem Phys Lipids 158 2009 1 9
51. S. Butterfield, and H. Lashuel Amyloidogenic protein-membrane interactions: mechanistic insight from model systems Angew Chem Int Ed 49 2010 5628 5654
52. K. Matsuzaki Physicochemical interactions of amyloid [beta]-peptide with lipid bilayers Biochim Biophys Acta-Biomembr 1768 2007 1935 1942
53. P.M. Pifer, E.A. Yates, and J. Legleiter Point mutations in A beta result in the formation of distinct polymorphic aggregates in the presence of lipid bilayers PLoS One 6 2011 e16248
54. P.T. Wong, J.A. Schauerte, K.C. Wisser, H. Ding, E.L. Lee, and D.G. Steel et al. Amyloid-β membrane binding and permeabilization are distinct processes influenced separately by membrane charge and fluidity J Mol Biol 386 2009 81 96
55. B.D. van Rooijen, M.M.A.E. Claessens, and V. Subramaniam Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core Biochim Biophys Acta-Biomembr 1788 2009 1271 1278
56. H. Ahyayauch, M. Raab, J.V. Busto, N. Andraka, J.R. Arrondo, and M. Masserini et al. Binding of beta-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies Biophys J 103 2012 453 463
57. H. Ding, J. Schauerte, D. Steel, and A. Gafni β-Amyloid (1-40) peptide interactions with supported phospholipid membranes: a single-molecule study Biophys J 103 2012 1500 1509
58. P.K. Auluck, G. Caraveo, and S. Lindquist Alpha-synuclein: membrane interactions and toxicity in Parkinson's disease Annu Rev Cell Dev Biol 26 2010 211 233
59. L. Kjaer, L. Giehm, T. Heimburg, and D. Otzen The influence of vesicle size and composition on alpha-synuclein structure and stability Biophys J 96 2009 2857 2870
60. B.D. van Rooijen, M.M.A.E. Claessens, and V. Subramaniam Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing FEBS Lett 582 2008 3788 3792
61. G. De Franceschi, E. Frare, M. Pivato, A. Relini, A. Penco, and E. Greggio et al. Structural and morphological characterization of aggregated species of alpha-synuclein induced by docosahexaenoic acid J Biol Chem 286 2011 22262 22274
62. C.C. Jao, B.G. Hegde, J. Chen, I.S. Haworth, and R. Langen Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement Proc Natl Acad Sci U S A 105 2008 19666 19671
63. E.R. Georgieva, T.F. Ramlall, P.P. Borbat, J.H. Freed, and D. Eliezer Membrane-bound alpha-synuclein forms an extended helix: long-distance pulsed ESR measurements using vesicles, bicelles, and rodlike micelles J Am Chem Soc 130 2008 12856
64. A.J. Trexler, and E. Rhoades Alpha-synuclein binds large unilamellar vesicles as an extended helix Biochemistry 48 2009 2304 2306
65. J. Varkey, N. Mizuno, B.G. Hegde, N. Cheng, A.C. Steven, and R. Langen Alpha-synuclein oligomers with broken helical conformation form lipoprotein nanoparticles J Biol Chem 288 2013 17620 17630
66. T. Al Kayal, E. Russo, L. Pieri, G. Caminati, D. Berti, and M. Bucciantini et al. Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation Soft Matter 8 2012 9115 9126
67. H. Li, S. Ye, F. Wei, S. Ma, and Y. Luo In Situ Molecular-Level Insights into the Interfacial Structure Changes of Membrane-Associated Prion Protein Fragment [118-135] Investigated by Sum Frequency Generation Vibrational Spectroscopy Langmuir 28 2012 16979 16988
68. K. Yanagisawa Pathological significance of ganglioside clusters in Alzheimer's disease J Neurochem 116 2011 806 812
69. T. Ariga, C. Wakade, and R.K. Yu The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis Int J Alzheimers Dis 2011 2011 193618
70. S. Fukunaga, H. Ueno, T. Yamaguchi, Y. Yano, M. Hoshino, and K. Matsuzaki GM1 cluster mediates formation of toxic A beta fibrils by providing hydrophobic environments Biochemistry 51 2012 8125 8131
71. C. Canale, S. Torrassa, P. Rispoli, A. Relini, R. Rolandi, and M. Bucciantini et al. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers Biophys J 91 2006 4575 4588
72. G. Anderluh, I. Gutierrez-Aguirre, S. Rabzelj, S. Ceru, N. Kopitar-Jerala, and P. Macek et al. Interaction of human stefin B in the prefibrillar oligomeric form with membranes - correlation with cellular toxicity FEBS J 272 2005 3042 3051
73. S. Ceru, S.J. Kokalj, S. Rabzelj, M. Skarabot, I. Gutierrez-Aguirre, and N. Kopitar-Jerala et al. Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B Amyloid 15 2008 147 159
74. M. Engel, H. Yigittop, R. Elgersma, D. Rijkers, R. Liskamp, and B. de Kruijff et al. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer J Mol Biol 356 2006 783 789
75. C. Lee, Y. Sun, and H.W. Huang How type II diabetes-related islet amyloid polypeptide damages lipid bilayers Biophys J 102 2012 1059 1068
76. P. Calvez, S. Bussières, D. Éric, and C. Salesse Parameters modulating the maximum insertion pressure of proteins and peptides in lipid monolayers Biochimie 91 2009 718 733
77. G. Brezesinski, E. Maltseva, and H. Moehwald Adsorption of amyloid beta (1-40) peptide at liquid interfaces Z Phys Chem Int J Res Phys Chem Chem Phys 221 2007 95 111
78. J.C.P. Damalio, T.M. Nobre, J.L. Lopes, O.N. Oliveira Jr., and A.P.U. Araujo Lipid interaction triggering Septin2 to assembly into beta-sheet structures investigated by Langmuir monolayers and PM-IRRAS Biochim Biophys Acta-Biomembr 2013 1828 1441 1448
79. E.M. Jones, M. Dubey, P.J. Camp, B.C. Vernon, J. Biernat, and E. Mandelkow et al. Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption Biochemistry (N.Y.) 51 2012 2539 2550
80. G. Thakur, C. Pao, M. Micic, S. Johnson, and R.M. Leblanc Surface chemistry of lipid raft and amyloid Aβ (1-40) Langmuir monolayer Colloids Surf B Biointerfaces 87 2011 369 377
81. C. Di Scala, N. Yahi, C. Lelievre, N. Garmy, H. Chahinian, and J. Fantini Biochemical identification of a linear cholesterol-binding domain within Alzheimer's beta amyloid peptide ACS Chem Neurosci 4 2013 509 517
82. M.P. Williamson, Y. Suzuki, N.T. Bourne, and T. Asakura Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13 Biochem J 397 2006 483 490
83. J. Fantini, N. Yahi, and N. Garmy Cholesterol accelerates the binding of Alzheimer's beta-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation Front Physiol 4 2013 120
84. J. Fantini, and N. Yahi Molecular basis for the glycosphingolipid-binding specificity of alpha-synuclein: key role of tyrosine 39 in membrane insertion J Mol Biol 408 2011 654 669
85. J. Fantini, D. Carlus, and N. Yahi The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain Biochim Biophys Acta-Biomembr 2011 1808 2343 2351
86. S. Dante, T. Hauss, R. Steitz, C. Canale, and N.A. Dencher Nanoscale structural and mechanical effects of beta-amyloid (1-42) on polymer cushioned membranes: a combined study by neutron reflectometry and AFM force spectroscopy Biochim Biophys Acta-Biomembr 2011 1808 2646 2655
87. K. Sasahara, K. Morigaki, and K. Shinya Effects of membrane interaction and aggregation of amyloid beta-peptide on lipid mobility and membrane domain structure Phys Chem Chem Phys 15 2013 8929 8939
88. K. Sasahara, K. Morigaki, T. Okazaki, and D. Hamada Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes Biochemistry 51 2012 6908 6919
89. L. Mapelli, C. Canale, D. Pesci, S. Averaimo, F. Guizzardi, and V. Fortunati et al. Toxic effects of expanded ataxin-1 involve mechanical instability of the nuclear membrane Biochim Biophys Acta (BBA) - Mol Basis Dis 1822 2012 906 917
90. K.A. Burke, E.A. Yates, and J. Legeiter Amyloid-forming proteins alter the local mechanical properties of lipid membranes Biochemistry 52 2013 808 817
91. G. Valincius, F. Heinrich, R. Budvytyte, D.J. Vanderah, D.J. McGillivray, and Y. Sokolov et al. Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity Biophys J 95 2008 4845 4861
92. H. Huang, F. Chen, and M. Lee Molecular mechanism of peptide-induced pores in membranes Phys Rev Lett 92 2004 198304
93. N. Arispe, H.B. Pollard, and E. Rojas Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes Proc Natl Acad Sci U S A 90 1993 10573 10577
94. P. Prangkio, E.C. Yusko, D. Sept, J. Yang, and M. Mayer Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity PLoS One 7 2012 e47261
95. T. Mirzabekov, M. Lin, and B. Kagan Pore formation by the cytotoxic islet amyloid peptide amylin J Biol Chem 271 1996 1988 1992
96. A. Quist, L. Doudevski, H. Lin, R. Azimova, D. Ng, and B. Frangione et al. Amyloid ion channels: a common structural link for protein-misfolding disease Proc Natl Acad Sci U S A 102 2005 10427 10432
97. M.J. Volles, and P.T. Lansbury Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 2002 4595 4602
98. J. Kourie, and A. Culverson Prion peptide fragment PrP[106-126] forms distinct cation channel types J Neurosci Res 62 2000 120 133
99. C. Seuring, J. Greenwald, C. Wasmer, R. Wepf, S.J. Saupe, and B.H. Meier et al. The mechanism of toxicity in HET-S/HET-s prion incompatibility PLoS Biol 10 2012 e1001451
100. R. Kayed, Y. Sokolov, B. Edmonds, T. McIntire, S. Milton, and J. Hall et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J Biol Chem 279 2004 46363 46366
101. B.L. Kelly, and A. Ferreira Beta-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons J Biol Chem 281 2006 28079 28089 10.1074/jbc.M605081200
102. 2 + increase in primary neuronal cells J Biol Chem 283 2008 29950 29960
103. L. Texido, M. Martin-Satue, E. Alberdi, C. Solsona, and C. Matute Amyloid beta peptide oligomers directly activate NMDA receptors Cell Calcium 49 2011 184 190
104. L. Connelly, H. Jang, F.T. Arce, R. Capone, S.A. Kotler, and S. Ramachandran et al. Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's beta-amyloid peptide: relevance to the ion channel mechanism of AD pathology J Phys Chem B 116 2012 1728 1735
105. J.A. Schauerte, P.T. Wong, K.C. Wisser, H. Ding, D.G. Steel, and A. Gafni Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of a beta species on lipid bilayers Biochemistry 49 2010 3031 3039
106. M.F.M. Sciacca, S.A. Kotler, J.R. Brender, J. Chen, D. Lee, and A. Ramamoorthy Two-step mechanism of membrane disruption by a beta through membrane fragmentation and pore formation Biophys J 103 2012 702 710
107. J.R. Brender, D.L. Heyl, S. Samisetti, S.A. Kotler, J.M. Osborne, and R.R. Pesaru et al. Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments Phys Chem Chem Phys 15 2013 8908 8915
108. N.B. Last, E. Rhoades, and A.D. Miranker Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity Proc Natl Acad Sci U S A 108 2011 9460 9465
109. L. Khemtemourian, M.F.M. Engel, R.M.J. Liskamp, J.W.M. Hoppener, and J.A. Killian The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition Biochim Biophys Acta-Biomembr 1798 2010 1805 1811
110. M.T. Stöckl, N. Zijlstra, and V. Subramaniam Alpha-synuclein oligomers: an amyloid pore? Mol Neurobiol 47 2013 613 621
111. L. Tosatto, A.O. Andrighetti, N. Plotegher, V. Antonini, I. Tessari, and L. Ricci et al. Alpha-synuclein pore forming activity upon membrane association Biochim Biophys Acta-Biomembr 2012 1818 2876 2883
112. L. Milanesi, T. Sheynis, W.F. Xue, E.V. Orlova, A.L. Hellewell, and R. Jelinek et al. Direct three-dimensional visualization of membrane disruption by amyloid fibrils Proc Natl Acad Sci U S A 109 2012 20455 20460
113. M.F.M. Engel, L. Khemtemourian, C.C. Kleijer, H.J.D. Meeldijk, J. Jacobs, and A.J. Verkleij et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane Proc Natl Acad Sci U S A 105 2008 6033 6038
114. L. Pieri, K. Madiona, L. Bousset, and R. Melki Fibrillar alpha-synuclein and huntingtin exon 1 assemblies are toxic to the cells Biophys J 102 2012 2894 2905
115. M. Stefani Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity FEBS J 277 2010 4602 4613
116. 2 + deregulation by different mechanisms in cerebellar granule cells BBA-Mol Cell Res 2013 1833 3155 3165
117. K.A. Burke, K.J. Kauffman, C.S. Umbaugh, S.L. Frey, and J. Legleiter The interaction of polyglutamine peptides with lipid membranes is regulated by flanking sequences associated with huntingtin J Biol Chem 288 2013 14993 15005
118. L. Khemtemourian, E. Domenech, J.P.F. Doux, M.C. Koorengevel, and J.A. Killian Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide J Am Chem Soc 133 2011 15598 15604
119. L. Arnaudov, and R. de Vries Thermally induced fibrillar aggregation of hen egg white lysozyme Biophys J 88 2005 515 526
120. E. Shehi, P. Fusi, F. Secundo, S. Pozzuolo, A. Bairati, and P. Tortora Temperature-dependent, irreversible formation of amyloid fibrils by a soluble human ataxin-3 carrying a moderately expanded polyglutamine stretch (Q36) Biochemistry 42 2003 14626 14632
121. V. Babenko, M. Piejko, S. Wojcik, P. Mak, and W. Dzwolak Vortex-induced amyloid superstructures of insulin and its component A and B chains Langmuir 29 2013 5271 5278
122. A. Sicorello, S. Torrassa, G. Soldi, S. Gianni, C. Travaglini- Allocatelli, and N. Taddei et al. Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions Biophys J 96 2009 2289 2298
123. G. Fuertes, D. Gimenez, S. Esteban-Martin, O.L. Sanchez-Munoz, and J. Salgado A lipocentric view of peptide-induced pores Eur Biophys J Biophys Lett 40 2011 399 415
124. H.W. Huang Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides Biophys J 96 2009 3263 3272
125. S.M. Gregory, A. Cavenaugh, V. Journigan, A. Pokorny, and P.F.F. Almeida A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A Biophys J 94 2008 1667 1680
126. P.H. Axelsen A chaotic pore model of polypeptide antibiotic action Biophys J 94 2008 1549 1550
127. N.B. Last, and A.D. Miranker Common mechanism unites membrane poration by amyloid and antimicrobial peptides Proc Natl Acad Sci U S A 110 2013 6382 6387
128. J. Seeliger, F. Evers, C. Jeworrek, S. Kapoor, K. Weise, and E. Andreetto et al. Cross-amyloid interaction of A beta and IAPP at lipid membranes Angew Chem Int Ed 51 2012 679 683
129. M.R. Nicolls The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease Curr Alzheimer Res 1 2004 47 54
130. T. Murtola, A. Bunker, I. Vattulainen, M. Deserno, and M. Karttunen Multiscale modeling of emergent materials: biological and soft matter Phys Chem Chem Phys 11 2009 1869 1892
131. D.E. Shaw, M.M. Deneroff, R.O. Dror, J.S. Kuskin, R.H. Larson, and J.K. Salmon et al. Anton, a special-purpose machine for molecular dynamics simulation Commun ACM 51 2008 91 97
132. T. Kim, G.S. Vidal, M. Djurisic, C.M. William, M.E. Birnbaum, and K.C. Garcia et al. Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model Science 341 2013 1399 1404